Whittier Trust Co. of Nevada Inc. Has $26,000 Stock Holdings in Humana Inc. (NYSE:HUM)

Whittier Trust Co. of Nevada Inc. trimmed its position in Humana Inc. (NYSE:HUM) by 45.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 101 shares of the insurance provider’s stock after selling 84 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Humana were worth $26,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of HUM. Transcend Capital Advisors LLC lifted its position in shares of Humana by 399.7% in the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC lifted its holdings in Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after purchasing an additional 26,856 shares during the last quarter. Retirement Systems of Alabama lifted its holdings in Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after purchasing an additional 65,735 shares during the last quarter. Finally, PDT Partners LLC raised its position in shares of Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares during the period. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on HUM shares. Truist Financial upped their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Piper Sandler upped their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. Cantor Fitzgerald reissued a “neutral” rating and set a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Finally, Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Eighteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $285.68.

Insider Buying and Selling at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Humana Stock Up 2.1 %

HUM stock opened at $271.65 on Tuesday. The firm has a 50-day moving average price of $271.01 and a 200-day moving average price of $275.60. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $32.79 billion, a P/E ratio of 27.30, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. Humana’s payout ratio is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.